183 related articles for article (PubMed ID: 11463790)
21. Approaches to improve metabolic stability of a statine-based GRP receptor antagonist.
Popp I; Del Pozzo L; Waser B; Reubi JC; Meyer PT; Maecke HR; Gourni E
Nucl Med Biol; 2017 Feb; 45():22-29. PubMed ID: 27865999
[TBL] [Abstract][Full Text] [Related]
22. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
[TBL] [Abstract][Full Text] [Related]
23. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.
Lin JT; Coy DH; Mantey SA; Jensen RT
Eur J Pharmacol; 1995 Dec; 294(1):55-69. PubMed ID: 8788416
[TBL] [Abstract][Full Text] [Related]
25. Four amino acid residues are critical for high affinity binding of neuromedin B to the neuromedin B receptor.
Sainz E; Akeson M; Mantey SA; Jensen RT; Battey JF
J Biol Chem; 1998 Jun; 273(26):15927-32. PubMed ID: 9632639
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
[TBL] [Abstract][Full Text] [Related]
27. Identification of four amino acids in the gastrin-releasing peptide receptor that are required for high affinity agonist binding.
Akeson M; Sainz E; Mantey SA; Jensen RT; Battey JF
J Biol Chem; 1997 Jul; 272(28):17405-9. PubMed ID: 9211882
[TBL] [Abstract][Full Text] [Related]
28. Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
González N; Mantey SA; Pradhan TK; Sancho V; Moody TW; Coy DH; Jensen RT
Peptides; 2009 Aug; 30(8):1473-86. PubMed ID: 19463875
[TBL] [Abstract][Full Text] [Related]
29. Biological evaluation of (177)Lu-labeled DOTA-Ala(SO3H)-Aminooctanoyl-Gln-Trp-Ala-Val-N methyl Gly-His-Statine-Leu-NH2 for gastrin-releasing peptide receptor-positive prostate tumor targeting.
Lim JC; Cho EH; Kim JJ; Choi SM; Lee Sy; Nam SS; Park UJ; Park SH
Nucl Med Biol; 2015 Feb; 42(2):131-6. PubMed ID: 25457455
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
31. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity.
Iwabuchi M; Ui-Tei K; Yamada K; Matsuda Y; Sakai Y; Tanaka K; Ohki-Hamazaki H
Br J Pharmacol; 2003 Jun; 139(3):555-66. PubMed ID: 12788815
[TBL] [Abstract][Full Text] [Related]
33. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
34. Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, (111)in-labeling, and preclinical profile.
Marsouvanidis PJ; Nock BA; Hajjaj B; Fehrentz JA; Brunel L; M'Kadmi C; van der Graaf L; Krenning EP; Maina T; Martinez J; de Jong M
J Med Chem; 2013 Mar; 56(6):2374-84. PubMed ID: 23427837
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors.
Mansi R; Abiraj K; Wang X; Tamma ML; Gourni E; Cescato R; Berndt S; Reubi JC; Maecke HR
J Med Chem; 2015 Jan; 58(2):682-91. PubMed ID: 25474596
[TBL] [Abstract][Full Text] [Related]
36. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN
Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X
Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329
[TBL] [Abstract][Full Text] [Related]
37. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
38. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
[TBL] [Abstract][Full Text] [Related]
39. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
